Common Cold
📧 Sign up to get email alerts when something new happens for Common Cold.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study
The RHINO study is a clinical trial investigating nasal-airway omics in rhinovirus infections and is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin [Phase 4]
A Phase 4 study evaluated quality-of-life outcomes after Robitussin treatment in individuals with a common cold or cough. The results have b…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study of APL-10456-Vaccine [EARLY_Phase 1]
Early-phase 1 study of APL-10456-Vaccine by Apollo Therapeutics Ltd is recruiting for rhinovirus-related indications (common cold).
-
FDA approval · 2025-12-29FDA Approved: PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (WALGREEN CO.)
FDA approved Walgreens' original application for pseudoephedrine hydrochloride as a generic drug, enabling market authorization for this dec…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula [NA]
A completed clinical trial indicates improved immunology outcomes in infants fed formula fortified with lactoferrin and human milk oligosacc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Evaluation of a Hypertonic Seawater Aerosol Therapy Solution in Adults and Children [NA]
A clinical trial is evaluating a hypertonic seawater aerosol therapy for upper respiratory tract infections and rhinitis in adults and child…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Post-market Clinical Follow-up Study of an Isotonic Saline Solution to Manage Nasal Congestion in Case of Flu Symptoms, Colds, Allergic Rhinitis and Rhinosinusitis in Infants and Toddlers
A post-market clinical follow-up study is planned (not yet recruiting) to evaluate the safety and effectiveness of an isotonic saline nasal …
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Throat Spray on the Incidence and Duration of Sickness [NA]
This clinical trial update describes a randomized, triple-blind, placebo-controlled study evaluating the effects of a throat spray on the in…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment [Phase 3]
A Phase 3 trial evaluating a fixed-dose combination of paracetamol, fexofenadine, and phenylephrine for cold and flu symptoms has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Effectiveness of a Nasal Spray on Viral Respiratory Infections [NA]
A completed clinical trial sponsored by CEN Biotech evaluated the effectiveness of an unspecified nasal spray against viral respiratory infe…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Supporting Parents to Choose Wisely [NA]
A completed University of Alberta clinical trial evaluated decision-support tools to help parents choose care for children with several comm…
-
FDA approval · 2025-05-20FDA Approved: CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sun Pharmaceutical Industries' Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride, updat…
-
FDA approval · 2025-04-15FDA Approved: RUGBY MUCUS RELIEF ER — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Mucus Relief ER (guaifenesin) from Rugby Laboratories, allowing the generic product to be …
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Taxifolin/ergothioneine and Immune Biomarkers in Healthy Volunteers (TaxEr) [NA]
Clinical trial update on a Taxifolin and ergothioneine combination (TaxEr) in healthy volunteers, assessing immune biomarkers with condition…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Efficacy and Safety of Silfamin for Common Cold [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of Silfamin for the common cold and sore throat has completed.
-
FDA approval · 2025-01-27FDA Approved: IPRATROPIUM BROMIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' original application for ipratropium bromide, a generic formulation of the anticholinergic bronchodilato…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)
The SYMBIOFILM-TAK clinical trial evaluating Symbiofilm in allergic children has completed and posted results.
-
CLINICAL_TRIALS other · 2024-12-09Clinical Trial Update: Effects of LP28 on Immunity Enhancement in the Elderly [NA]
This clinical trial update indicates that Synbio Tech Inc. is recruiting for a study of the LP28 probiotic to enhance immunity in elderly in…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Effect of a Multistrain Probiotic on Cold Symptoms in Healthy Patients with an History of Upper Airways Infection [NA]
A completed clinical trial evaluated the effect of a multistrain probiotic on cold symptoms in healthy adults with a history of upper airway…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of Antiwei Granules for the treatment of the common cold is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection [Phase 3]
Phase 3 trial evaluating nitazoxanide for treatment of colds caused by enterovirus or rhinovirus was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Testing the Efficacy in Adults With Cold of HEalsea Rescue* [NA]
A completed clinical trial evaluating HEalsea Rescue for the common cold has posted results; the study was sponsored by Lallemand Pharma AG.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: BАbykids Spray In Common Cold [NA]
The clinical trial evaluating Babykids Spray for the common cold and viral rhinitis has completed and results have been posted.
-
CLINICAL_TRIALS other · 2024-10-03Clinical Trial Update: Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects [NA]
Clinical trial update indicates termination of a pediatric study evaluating two seawater-based nasal formulations for relief of nasal conges…
-
CLINICAL_TRIALS withdrawal · 2024-09-26Clinical Trial Update: Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold [Phase 3]
A Phase 3 trial evaluating the combination of acetylcysteine, paracetamol and phenylephrine for the common cold has been withdrawn. Sponsor:…